AI Verdict
RLI has stronger fundamentals based on our AI analysis.
RLI vs RLFTF Fundamental Comparison
| Metric | RLI | RLFTF |
|---|---|---|
| Revenue | $1.9B | N/A |
| Net Income | $403.3M | N/A |
| Net Margin | 21.4% | N/A |
| ROE | 22.7% | N/A |
| ROA | 6.5% | N/A |
| Current Ratio | N/A | N/A |
| Debt/Equity | 0.06x | N/A |
| EPS | $4.37 | N/A |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RLI vs RLFTF: Frequently Asked Questions
Is RLI or RLFTF a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RLI has stronger fundamentals. RLI is rated BUY (72% confidence) while RLFTF is rated SELL (25% confidence). This is not investment advice.
How does RLI compare to RLFTF fundamentally?
RLI CORP has ROE of 22.7% vs Relief Therapeutics Holding SA's N/A. Net margins are 21.4% vs N/A respectively.
Which stock pays higher dividends, RLI or RLFTF?
RLI has a dividend yield of N/A or no dividend while RLFTF has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RLI or RLFTF for long term?
For long-term investing, consider that RLI has BUY rating with 72% confidence, while RLFTF has SELL rating with 25% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RLI vs RLFTF?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RLI vs RLFTF, the AI consensus favors RLI based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.